Aesthetic Treatments for Acne-Prone Skin Types

Last updated: 9 August 2026

The challenge of treating acne-prone skin in aesthetics

Acne-prone skin presents unique challenges in the aesthetic clinic. Patients with active or historic acne often have multiple overlapping concerns, active breakouts, post-inflammatory hyperpigmentation, atrophic scarring, enlarged pores, and oily skin, that require a carefully layered approach. The wrong treatment, or the right treatment at the wrong time, can trigger flares, worsen scarring, or cause complications that would not occur in non-acne-prone skin.

Practitioners have extensive experience treating acne-prone skin types. We understand that these patients often feel frustrated after years of ineffective treatments and need both clinical expertise and clear, honest communication about what is achievable and the timeframe involved.

Understanding acne pathophysiology

Effective treatment of acne-prone skin requires understanding the four pathological factors that drive acne formation:

1. Sebum overproduction: Androgen-stimulated sebaceous glands produce excess sebum, creating an oily, comedone-prone environment.
2. Follicular hyperkeratinisation: Abnormal keratinocyte behaviour within hair follicles causes “plugging” of the follicular opening, trapping sebum beneath the surface.
3. Cutibacterium acnes (C. Acnes) proliferation: This commensal bacterium thrives in the anaerobic, lipid-rich environment of plugged follicles, triggering inflammatory responses.
4. Inflammation: Both the innate and adaptive immune systems mount inflammatory responses to bacterial products and follicular contents, producing the papules, pustules, and cysts that characterise inflammatory acne.

Treatment strategies must address one or more of these pathological factors, and aesthetic treatments can be powerful adjuncts to pharmacological management.

Aesthetic treatments for active acne

LED Light Therapy

LED therapy is one of the safest and most evidence-based treatments for acne-prone skin:

• Red light (633nm): Anti-inflammatory action reduces the erythema and swelling of active lesions. Also stimulates fibroblast activity, supporting repair of acne-damaged skin.
• Combined blue-red therapy: Evidence suggests that alternating or simultaneous blue and red wavelengths produces superior results to either alone, combining antibacterial and anti-inflammatory effects.

Chemical peels for acne

Carefully selected chemical peels can significantly improve acne by addressing both comedonal and inflammatory components:

Salicylic acid (20–30%): The gold standard for acne-prone skin. As a lipophilic BHA, salicylic acid penetrates into sebaceous follicles, dissolving the keratin plugs that cause comedones and exerting direct anti-inflammatory action. A randomised controlled trial in Dermatologic Surgery (2023) showed that biweekly salicylic acid peels reduced total lesion counts by 52% and comedone counts by 45% over 12 weeks.

Mandelic acid (30–50%): An alpha-hydroxy acid with antibacterial properties, particularly useful for acne in darker skin types where the risk of post-inflammatory hyperpigmentation (PIH) from stronger peels is a concern.

Azelaic acid (20–30%): Inhibits tyrosinase (reducing PIH), has antimicrobial activity against C. Acnes, and normalises follicular keratinisation. An excellent choice for patients with acne plus pigmentation concerns.

Jessner’s peel: A combination of salicylic acid, lactic acid, and resorcinol. Provides deeper exfoliation for stubborn comedonal acne. Requires careful use in darker skin types.

HydraFacial-type treatments

Aqua-peel or vortex-based treatments (such as HydraFacial) combine cleansing, exfoliation, extraction, and serum infusion in a single session. For acne-prone skin, the extraction step is particularly valuable, which gives mechanical removal of comedones under controlled, hygienic conditions. Evidence in Journal of Cosmetic Dermatology (2023) showed improvement in comedone counts, pore appearance, and skin hydration after a course of 4 weekly treatments.

Treating post-acne concerns

Post-inflammatory hyperpigmentation (PIH)

PIH, the dark marks left after inflammatory acne lesions resolve, is often more distressing to patients than the acne itself. It disproportionately affects darker skin types (Fitzpatrick III–VI). Evidence-based treatments include:

• Topical depigmenting agents: Azelaic acid (15–20%), vitamin C (10–20%), tranexamic acid, niacinamide (5%), and arbutin. These are first-line and should be used consistently for 3–6 months.
• Chemical peels: Mandelic acid and glycolic acid peels accelerate pigment clearance by promoting epidermal turnover.
• Microneedling: Shallow microneedling (0.25–0.5mm) with vitamin C or tranexamic acid serum enhances penetration of depigmenting actives.
• IPL and laser: Used with caution in darker skin types. Q-switched Nd:YAG at low fluence is the safest option for laser-based PIH treatment in Fitzpatrick IV–VI.

Atrophic acne scarring

Acne scars are classified into three morphological types, each requiring different treatment approaches:

Ice pick scars (deep, narrow): TCA CROSS technique (Chemical Reconstruction of Skin Scars), focal application of 70–100% trichloroacetic acid to individual scars, is the most evidence-based treatment. Subcision (releasing the tethered scar base with a needle) may be combined.

Boxcar scars (wider, defined edges): Fractional laser (CO2 or erbium) is the treatment of choice. Microneedling at 1.5–2.5mm also shows significant benefit.

Rolling scars (broad, undulating): Subcision to release fibrous tethers, followed by filler placement to support the released tissue, combined with fractional laser or microneedling for surface improvement.

Enlarged Pores

While true pore size cannot be permanently reduced, the appearance of pores can be improved through regular retinoid use, fractional laser or microneedling (promoting collagen around the pore opening), and chemical peels to maintain follicular patency.

What to avoid in acne-prone skin

Certain aesthetic treatments can exacerbate acne or cause complications:

• Heavy, occlusive moisturisers post-treatment: Rich wound-care products suitable for non-acne skin can trigger breakouts in acne-prone patients. Use non-comedogenic alternatives.
• Aggressive ablative treatments during active acne: Full ablative laser resurfacing over active inflammatory acne risks spreading infection and worsening scarring.
• Dermal fillers near active acne: Injecting filler into or near actively inflamed skin increases infection risk and can cause biofilm formation. Wait until active acne is controlled.
• Comedogenic topical products: Some post-procedure products contain oils or silicones that occlude pores. Always specify non-comedogenic alternatives for acne-prone patients.

Building a comprehensive acne treatment plan

We follow a phased approach:

Phase 1, Control (Months 1–3): Establish a medical-grade skincare routine (salicylic acid cleanser, niacinamide, retinoid, SPF 30+). LED blue light therapy biweekly. Salicylic acid peels monthly. Address active breakouts before treating scars.

Phase 2, Correct (Months 3–9): Once active acne is controlled, begin scar treatment (microneedling, laser, TCA CROSS as appropriate). Address PIH with targeted treatments. Continue maintenance skincare and monthly peels.

Phase 3, Maintain (Ongoing): Quarterly peels and/or LED therapy. Consistent retinoid use. Annual reassessment of skin concerns and treatment plan adjustment.

Key Takeaways

• Acne-prone skin requires phased treatment, control active acne before treating scars and pigmentation
• LED light therapy and salicylic acid peels are safe, effective first-line aesthetic treatments for active acne
• Different scar types (ice pick, boxcar, rolling) require different treatment approaches
• Post-inflammatory hyperpigmentation needs targeted depigmenting strategies, especially in darker skin types
• All post-treatment products and wound-care protocols must be adapted for acne-prone skin